Expectation and perspectives of patients and physicians on new treatment for early Alzheimer Disease: Results of a physician survey and patient focus group interview
Joanne Bell, H Ricky Kurzman, Stephane Borentain, Russ Paulsen, Andrew Holzapfel, Harald Hampel · 2025
Read Expectation and perspectives of patients and physicians on new treatment for early Alzheimer Disease: Results of a physician survey and patient focus group interview by Joanne Bell, H Ricky Kurzman, Stephane Borentain, Russ Paulsen, Andrew Holzapfel, Harald Hampel (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712053.txt.
Description
Joanne Bell and co-authors report a 2025 study of what patients and doctors expect from new Alzheimer's treatments. New drugs that slow the disease are now approved, so doctors must explain their effects clearly. The team first surveyed one hundred United States specialists, then ran six focus groups with patients and care partners.
Doctors said memory loss worried patients most, and most doctors expected the new drugs to slow decline over time. Patients cared most about money strain, lost social contact, and lost independence. Both sides valued holding on to daily skills and quality of life. The authors call for better talks and tools that help set fair expectations.
Catalog record
| CREATOR | Joanne Bell, H Ricky Kurzman, Stephane Borentain, Russ Paulsen, Andrew Holzapfel, Harald Hampel |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |